McKenna Mark C. bought NAMS
January 7, 2026 · Form 4 insider transaction
McKenna Mark C. bought 3,400 shares of NewAmsterdam Pharma Company N.V., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,400
Price
N/A
Total value
N/A
InsiderMcKenna Mark C.
RoleDirector
SecurityOrdinary Shares
Transaction codeA: Grant or award
Transaction dateJanuary 7, 2026
Filing dateJanuary 9, 2026
Shares owned after10,360
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units (RSUs), each representing a contingent right to receive one ordinary share. All of the RSUs will vest on the one-year anniversary of the vesting start date, subject to the Reporting Person's continued service through such date.; Each RSU was granted on January 7, 2026 for no consideration.